None listed
Conditions
Interventions
None listed
Sponsors
The Catholic University of Korea, Seoul St. Mary's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients who were newly diagnosed with de novo AML 2) Patients who had recurrent cytogenetic abnormalities of AML even though the bone marrow blast percent is lower than 20%
Exclusion criteria
Exclusion criteria: 1) Acute promyelocytic leukemia 2) Down syndrome AML 3) Therapy-related AML 4) AML developed from myelodysplastic syndrome or other marrow failure syndrome 5) Isolated myeloid sarcoma without bone marrow involvement 6) Patients who cannot undergo chemotherapy as scheduled due to serious complications at diagnosis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of event free survival | — |
Secondary
| Measure | Time frame |
|---|---|
| Proportion of patients who achieved complete remission | — |
Countries
Korea, Republic of
Contacts
Public ContactJi Won Lee
Samsung Medical Center
Outcome results
None listed